BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6346343)

  • 1. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism.
    Quinn D; Shirai K; Jackson RL
    Prog Lipid Res; 1983; 22(1):35-78. PubMed ID: 6346343
    [No Abstract]   [Full Text] [Related]  

  • 2. [The great Scandinavian Medical Jahre Prize 1994. Role of lipoprotein lipase in lipoprotein metabolism].
    Olivecrona T
    Nord Med; 1995; 110(1):4-8. PubMed ID: 7831108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-II and lipoprotein lipase activity.
    Catapano AL
    Ric Clin Lab; 1982; 12(1):35-40. PubMed ID: 7046021
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamics of C-apolipoproteins in the enzymatic interconversions of plasma lipoproteins.
    Kinnunen PK; Vainio P; Virtanen JA
    Ric Clin Lab; 1982; 12(1):41-9. PubMed ID: 7046022
    [No Abstract]   [Full Text] [Related]  

  • 5. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.
    Reckless JP; Stocks J; Holdsworth G
    Clin Sci (Lond); 1982 Feb; 62(2):125-9. PubMed ID: 7053911
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism.
    Cryer A
    Int J Biochem; 1981; 13(5):525-41. PubMed ID: 7016622
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of lipoprotein lipase by benzene boronic acid. Effect of apolipoprotein C-II.
    Vainio P; Virtanen JA; Kinnunen PK
    Biochim Biophys Acta; 1982 Jun; 711(3):386-90. PubMed ID: 7104374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
    Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW
    Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
    Kashyap ML; Srivastava LS; Hynd BA; Brady D; Perisutti G; Glueck CJ; Gartside PS
    Atherosclerosis; 1980 Jan; 35(1):29-40. PubMed ID: 7370086
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on duck serum lipoproteins. VIII. Studies on biological activity and metabolism of HDL-apo C II in vitro].
    Li XZ; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):89-94. PubMed ID: 2955931
    [No Abstract]   [Full Text] [Related]  

  • 13. Redistribution of apolipoproteins C removed from human very low density lipoprotein during in vitro lipolysis by lipoprotein lipase.
    Glangeaud-Freudenthal MC; Burdin J; Ayrault-Jarrier M; Polonovski J
    Biochimie; 1981 Jun; 63(6):485-94. PubMed ID: 7260173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase.
    Jackson RL; Tajima S; Yamamura T; Yokoyama S; Yamamoto A
    Biochim Biophys Acta; 1986 Feb; 875(2):211-9. PubMed ID: 3942763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
    Kashyap ML; de Mendoza SG; Campbell M; Chen CY; Lutmer RF; Glueck CJ
    Experientia; 1978 Aug; 34(8):1044-5. PubMed ID: 212287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
    Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
    Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
    Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
    Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization, structure and reaction mechanism of enzymes involved in plasma lipoprotein metabolism].
    Ikeda Y; Takagi A
    Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1529-45. PubMed ID: 3444891
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
    Catapano AL; Capurso A; Kinnunen PK
    Artery; 1981; 9(2):87-95. PubMed ID: 7295047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.
    Smith LC; Voyta JC; Catapano AL; Kinnunen PK; Gotto AM; Sparrow JT
    Ann N Y Acad Sci; 1980; 348():213-23. PubMed ID: 6930927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.